Janoshazi A, Seifter J L, Solomon A K
Biophysical Laboratory, Harvard Medical School, Boston, Massachusetts 02115.
J Membr Biol. 1989 Nov;112(1):39-49. doi: 10.1007/BF01871162.
In separated outer medullary collecting duct (MCD) cells, the time course of binding of the fluorescent stilbene anion exchange inhibitor, DBDS (4,4'-dibenzamido-2,2'-stilbene disulfonate), to the MCD cell analog of band 3, the red blood cell (rbc) anion exchange protein, can be measured by the stopped-flow method and the reaction time constant, tau TDBDS, can be used to report on the conformational state of the band 3 analog. In order to validate the method we have now shown that the ID50D,DBDS,MCD (0.5 +/- 0.1 microM) for the H2-DIDS (4,4'-diisothiocyano-2,2'-dihydrostilbene disulfonate) inhibition of tau DBDS is in agreement with the ID50,Cl-MCD (0.94 +/- 0.07 microM) for H2-DIDS inhibition of MCD cell Cl- flux, thus relating tau DBDS directly to anion exchange. The specific cardiac glycoside cation transport inhibitor, ouabain, not only modulates DBDS binding kinetics, but also increases the time constant for Cl- exchange by a factor of two, from tau Cl- = 0.30 +/- 0.02 sec to 0.56 +/- 0.06 sec (30 mM NaHCO3). The ID50,DBDS,MCD for the ouabain effect on DBDS binding kinetics is 0.003 +/- 0.001 microM, so that binding is about an order of magnitude tighter than that for inhibition of rbc K+ flux (KI,K+,rbc = 0.017 microM). These experiments indicate that the Na+,K+-ATPase, required to maintain cation gradients across the MCD cell membrane, is close enough to the band 3 analog that conformational information can be exchanged. Cytochalasin E (CE), which binds to the spectrin/actin complex in rbc and other cells. modulates DBDS binding kinetics with a physiological ID50,DBDS,MCD (0.076 +/- 0.005 microM); 2 microM CE also more than doubles the Cl- exchange time constant from 0.20 +/- 0.04 sec to 0.50 +/- 0.08 sec (30 mM NaHCO3). These experiments indicate that conformational information can also be exchanged between the MCD cell band 3 analog and the MCD cell cytoskeleton.
在分离的外髓集合管(MCD)细胞中,荧光芪阴离子交换抑制剂DBDS(4,4'-二苯甲酰胺基-2,2'-芪二磺酸盐)与红细胞(rbc)阴离子交换蛋白带3的MCD细胞类似物的结合时间进程,可用停流法测量,反应时间常数τTDBDS可用于报告带3类似物的构象状态。为了验证该方法,我们现已表明,H2-DIDS(4,4'-二异硫氰酸基-2,2'-二氢芪二磺酸盐)对τDBDS的抑制作用的ID₅₀D,DBDS,MCD(0.5±0.1微摩尔)与H2-DIDS对MCD细胞Cl⁻通量的抑制作用的ID₅₀,Cl-MCD(0.94±0.07微摩尔)一致,从而将τDBDS直接与阴离子交换联系起来。特异性强心苷阳离子转运抑制剂哇巴因不仅调节DBDS的结合动力学,还使Cl⁻交换的时间常数增加一倍,从τCl⁻ = 0.30±0.02秒增加到0.56±0.06秒(30 mM NaHCO₃)。哇巴因对DBDS结合动力学影响的ID₅₀,DBDS,MCD为0.003±0.001微摩尔,因此其结合比抑制rbc K⁺通量(KI,K⁺,rbc = 0.017微摩尔)的结合紧密约一个数量级。这些实验表明,维持MCD细胞膜阳离子梯度所需的Na⁺,K⁺-ATP酶与带3类似物足够接近,以至于构象信息可以交换。细胞松弛素E(CE)与rbc和其他细胞中的血影蛋白/肌动蛋白复合物结合,以生理ID₅₀D,DBDS,MCD(0.076±0.005微摩尔)调节DBDS的结合动力学;2微摩尔CE还使Cl⁻交换时间常数增加一倍多,从0.20±0.04秒增加到0.50±0.08秒(30 mM NaHCO₃)。这些实验表明,构象信息也可以在MCD细胞带3类似物和MCD细胞细胞骨架之间交换。